EA
Emerald Advisers Portfolio holdings
AUM
$2.73B
This Quarter Return
-2.67%
1 Year Return
+54.29%
3 Year Return
+280.05%
5 Year Return
+497.66%
10 Year Return
+2,067.91%
AUM
$2.06B
AUM Growth
+$2.06B
(-9.7%)
Cap. Flow
-$19M
Cap. Flow
% of AUM
-0.92%
Top 10 Holdings %
Top 10 Hldgs %
18.33%
Holding
249
New
38
Increased
87
Reduced
99
Closed
17
Top Buys
| 1 |
AAR Corp
AIR
|
$23.4M |
| 2 |
CBAY
Cymabay Therapeutics
CBAY
|
$14.7M |
| 3 |
IMGN
Immunogen Inc
IMGN
|
$13.1M |
| 4 |
RadNet
RDNT
|
$12.5M |
| 5 |
Weatherford International
WFRD
|
$11.6M |
Top Sells
| 1 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$32.3M |
| 2 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$27.5M |
| 3 |
Planet Fitness
PLNT
|
$27.5M |
| 4 |
Super Micro Computer
SMCI
|
$16.8M |
| 5 |
Petco
WOOF
|
$14.1M |
Sector Composition
| 1 | Healthcare | 27.32% |
| 2 | Industrials | 21.96% |
| 3 | Technology | 19.12% |
| 4 | Consumer Discretionary | 9.24% |
| 5 | Financials | 7.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
MACOM Technology Solutions
MTSI
$9.69B
| $23.2M | 1.12% |
284,444
-38,906
| -12% | -$3.17M |
|
27
ATI
ATI
$10.5B
| $23M | 1.11% |
558,505
+2,905
| +0.5% | +$120K |
|
28
Palomar
PLMR
$3.3B
| $22.9M | 1.11% |
451,538
+2
| +0% | +$102 |
|
29
Montrose Environmental
MEG
$1.01B
| $22.7M | 1.1% |
777,221
+298,629
| +62% | +$8.74M |
|
30
Herc Holdings
HRI
$4.2B
| $22.3M | 1.08% |
187,789
-399
| -0.2% | -$47.5K |
|
31
AtriCure
ATRC
$1.73B
| $21.9M | 1.06% |
498,972
+3
| +0% | +$131 |
|
|
BWIN
32
Baldwin Insurance Group
BWIN
$2.15B
| $21.7M | 1.05% |
934,086
-221
| -0% | -$5.13K |
|
33
Northern Oil and Gas
NOG
$2.5B
| $21.5M | 1.04% |
535,190
-304,393
| -36% | -$12.2M |
|
34
Skyward Specialty Insurance
SKWD
$1.98B
| $21M | 1.02% |
766,518
-498
| -0.1% | -$13.6K |
|
35
Privia Health
PRVA
$2.84B
| $20.9M | 1.01% |
908,858
+51,944
| +6% | +$1.19M |
|
36
Moelis & Co
MC
$5.21B
| $20.7M | 1% |
458,302
-443
| -0.1% | -$20K |
|
37
Exponent
EXPO
$3.63B
| $20.7M | 1% |
241,440
-40,203
| -14% | -$3.44M |
|
38
Rambus
RMBS
$7.93B
| $20.3M | 0.98% |
364,279
+75,033
| +26% | +$4.19M |
|
39
TETRA Technologies
TTI
$629M
| $20.3M | 0.98% |
3,182,502
-230,317
| -7% | -$1.47M |
|
|
ITCI
40
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $19.9M | 0.96% |
381,740
+46,574
| +14% | +$2.43M |
|
41
Treace Medical Concepts
TMCI
$458M
| $19.3M | 0.94% |
1,473,281
+107,143
| +8% | +$1.4M |
|
42
Celsius Holdings
CELH
$15.8B
| $19.1M | 0.93% |
111,434
-36,838
| -25% | -$6.32M |
|
43
BridgeBio Pharma
BBIO
$9.91B
| $18.3M | 0.89% |
694,000
+214,875
| +45% | +$5.67M |
|
44
PDF Solutions
PDFS
$758M
| $18.2M | 0.88% |
560,920
+29,363
| +6% | +$951K |
|
45
Replimune Group
REPL
$460M
| $18M | 0.87% |
1,052,524
-33,763
| -3% | -$578K |
|
46
Houlihan Lokey
HLI
$13.5B
| $17.9M | 0.87% |
166,969
-15,134
| -8% | -$1.62M |
|
|
CHX
47
DELISTED
ChampionX
CHX
| $17.8M | 0.86% |
500,445
-309,375
| -38% | -$11M |
|
48
Ultragenyx Pharmaceutical
RARE
$3.04B
| $17.5M | 0.85% |
491,689
-60,447
| -11% | -$2.15M |
|
49
indie Semiconductor
INDI
$856M
| $17.4M | 0.84% |
2,768,582
+672,284
| +32% | +$4.24M |
|
50
Valaris
VAL
$3.49B
| $17.1M | 0.83% |
227,985
+1
| +0% | +$75 |
|